Testosterone for Androgen Deficiency-Like Symptoms

Phase 4

Completed

• Conditions: Androgen deficiency; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12615000071527
• Lead Sponsor: Department of Andrology, Concord Repatriation General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-01-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Men aged 40 years or older
Believed to have androgen deficiency (AD)
Symptoms consistent with AD (according to US clinical guidelines)
Provides written, informed consent and is willing to comply with study requirements

Exclusion Criteria

Pathologically-based AD
Major chronic illness causing serious disability or with life expectancy less then 2 years in the opinion of the investigator
Major cardiovascular event (new or worsened angina, infarction, angioplasty, uncontrolled arrhythmia or hypertension) within the last 6 months
Contraindication to testosterone including prostate or breast cancer.
History of androgen or other drug abuse within last year.
History of HIV or viral hepatitis.
Skin disease that may interfere with transdermal drug administration.
History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements.
Regular use of medications that interfere with absorption, metabolism or action of testosterone and may require dosage change during the study.
Haematocrit over 0.50 or history of polycythaemia

Study & Design

• Study Type: Interventional
• Study Design: Not specified